HLA-independent T cell receptors for targeting tumors with low antigen density-Reference-Cited by-同舟云学术

HLA-independent T cell receptors for targeting tumors with low antigen density

Published:2022-01-13 Issue:2 Volume:28 Page:345-352
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Mansilla-Soto Jorge^ORCID,Eyquem Justin^ORCID,Haubner Sascha^ORCID,Hamieh Mohamad^ORCID,Feucht Judith,Paillon Noémie^ORCID,Zucchetti Andrés Ernesto,Li Zhuoning,Sjöstrand Maria,Lindenbergh Pieter L.,Saetersmoen Michelle,Dobrin Anton^ORCID,Maurin Mathieu,Iyer Archana,Garcia Angus Andreina,Miele Matthew M.^ORCID,Zhao Zeguo,Giavridis Theodoros,van der Stegen Sjoukje J. C.^ORCID,Tamzalit Fella,Rivière Isabelle,Huse Morgan^ORCID,Hendrickson Ronald C.,Hivroz Claire^ORCID,Sadelain Michel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-021-01621-1.pdf

Reference58 articles.

1. Sadelain, M., Riviere, I. & Riddell, S. Therapeutic T cell engineering. Nature 545, 423–431 (2017).

2. Eshhar, Z. et al. The T-body approach: potential for cancer immunotherapy. Springer Semin. Immunopathol. 18, 199–209 (1996).

3. Sadelain, M., Riviere, I. & Brentjens, R. Targeting tumours with genetically enhanced T lymphocytes. Nat. Rev. Cancer 3, 35–45 (2003).

4. Maher, J., Brentjens, R. J., Gunset, G., Riviere, I. & Sadelain, M. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor. Nat. Biotechnol. 20, 70–75 (2002).

5. van der Stegen, S. J., Hamieh, M. & Sadelain, M. The pharmacology of second-generation chimeric antigen receptors. Nat. Rev. Drug Discov. 14, 499–509 (2015).

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation;Science Advances;2024-09-06

2. ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights;Frontiers in Immunology;2024-09-05

3. Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding;Journal of Biological Chemistry;2024-09

4. The potential of γδ CAR and TRuC T cells: An unearthed treasure;European Journal of Immunology;2024-08-27

5. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors;Cellular & Molecular Immunology;2024-08-12